Wed. 7 Aug 2024, 4:20pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.47) by 10.64 percent. The company reported quarterly sales of $77.875 million which beat the analyst consensus estimate of $75.246 million by 3.49 percent. This is a 107.68 percent increase over sales of $37.497 million the same period last year.